Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06536439

Planning Operative Strategy Using a Digital Renal Artery Clamping Tool: a Randomized Controlled Trial Evaluating the DIPLANN 3D Model for Selective Arterial Clamping During Robot-Assisted Partial Nephrectomy

Led by University Hospital, Ghent · Updated on 2025-04-01

235

Participants Needed

5

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University Hospital, Ghent

Lead Sponsor

S

Stichting tegen Kanker

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating a new digital tool called the DIPLANN-tool to help plan kidney surgeries for patients with localized kidney cancer. This tool predicts kidney blood flow zones on a 3D model to guide selective clamping during robot-assisted partial nephrectomy (RAPN). The study aims to confirm if adding the DIPLANN-tool to conventional CT imaging improves surgical planning and outcomes compared to using CT imaging alone. Participants will be randomly assigned to one of two groups: one group will use the DIPLANN-tool combined with conventional CT imaging for preoperative planning and guidance during RAPN, while the other group will use only conventional CT imaging, which is the current standard of care. The study involves preoperative visits with physical exams, blood tests, and questionnaires, followed by the surgical procedure guided by the assigned imaging method. During the study, patients will undergo assessments including physical exams, blood tests, and questionnaires to evaluate health, anxiety, and quality of life before surgery. Researchers will measure how well selective clamping is planned and performed during surgery as the main outcome. Secondary outcomes include kidney function six months after surgery, surgical details like clamping strategy and dissection time, and any need to switch to full clamping. The study will track these results to assess the benefits of the DIPLANN-tool over standard imaging.

CONDITIONS

Brief Title

Planning Operative Strategy Using a Digital Renal Artery Clamping Tool

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 years or above
  • Diagnosed with cT1-2 N0 M0 renal mass
  • Planned to undergo robot-assisted partial nephrectomy (RAPN)
  • Multiphase CT scan available with arterial phase
  • Provided voluntary written informed consent
  • Sufficient proficiency in at least one study language: Dutch, English, or French
  • Selective clamping deemed possible by an independent surgeon based on imaging assessments
Not Eligible

You will not qualify if you...

  • More than 3 ipsilateral renal masses
  • Women who are pregnant or breastfeeding
  • Previous renal surgery expected to complicate kidney cancer surgery
  • Clinical tumor stage cT 3 or higher
  • Planned off-clamp tumor resection
  • Cognitive disorders that interfere with completing study questionnaires

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Pre-operative Planning

Duration - Up to 1 week before surgery

Participants attend a pre-operative study visit where the surgical procedure and clamping strategy are explained and planned using either the DIPLANN-tool with conventional CT imaging or conventional CT imaging alone. This includes a physical examination, blood tests, and questionnaires about patient knowledge, anxiety, and quality of life.

1 visit (in-person)

Surgery

Duration - Day of surgery

Participants undergo robot-assisted partial nephrectomy with peri-operative guidance using either the DIPLANN-tool plus CT imaging or CT imaging alone to assist in selective arterial clamping during the procedure.

1 visit (in-person, surgical procedure)

Post-operative Follow-up

Duration - 6 months postoperatively

Participants are monitored for health outcomes including kidney function and recovery after surgery.

Follow-up visits as scheduled by the clinical team

Trial Site Locations

Total: 5 locations

1

AZORG

Aalst, Belgium, 9300

Actively Recruiting

2

AZ Sint-Jan

Bruges, Belgium, 8000

Actively Recruiting

3

ZOL

Genk, Belgium, 3600

Actively Recruiting

4

AZ Maria Middelares

Ghent, Belgium, 9000

Actively Recruiting

5

Ghent University Hospital

Ghent, Belgium, 9000

Actively Recruiting

Loading map...

Research Team

J

Joris Vangeneugden, MD

C

Charles Van Praet, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A First-in-Human, Phase I/II PET Imaging Study of 64Cu-GRIP ...

Prostate Cancer

Actively Recruiting

1 location

A Prospective, Multicenter Study of Diagnostic Efficiency of...

Renal Cancer

Actively Recruiting

9 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Clinical trial protocol of PODRACING: A randomized controlled trial evaluating 3D perfusion zone models for selective arterial clamping during robot-assisted partial nephrectomy.

Joris Vangeneugden, Saar Vermijs, Pieter De Backer...

https://pubmed.ncbi.nlm.nih.gov/42022229

Three-dimensional Perfusion-zone Models Allow More Selective Clamping During Robot-assisted Partial Nephrectomy: Brief Report on a Retrospective Analysis.

Joris Vangeneugden, Saar Vermijs, Pieter De Backer...

https://pubmed.ncbi.nlm.nih.gov/41280160